Genes

Response

The first 2 of this page's 20 results. GET /api/genes/v1?page=24

{
  "data": {
    "total": 193990,
    "results": [
      {
        "id": "6256",
        "title": "RXRA: retinoid X receptor alpha",
        "summary": "NCBI Gene 6256. 1 protein, 95 patents, 8 drugs, 81 trials, 8,435 NIH grants and 15,812 papers.",
        "record": "/library/genes/6256",
        "gene_id": 6256,
        "symbol": "RXRA",
        "name": "retinoid X receptor alpha",
        "hgnc_id": "HGNC:10477",
        "counts": {
          "proteins": 1,
          "patents": 95,
          "drugs": 8,
          "trials": 81,
          "grants": 8435,
          "papers": 15812
        }
      },
      {
        "id": "3934",
        "title": "LCN2: lipocalin 2",
        "summary": "NCBI Gene 3934. 1 protein, 154 patents, 0 drugs, 0 trials, 5,229 NIH grants and 15,802 papers.",
        "record": "/library/genes/3934",
        "gene_id": 3934,
        "symbol": "LCN2",
        "name": "lipocalin 2",
        "hgnc_id": "HGNC:6526",
        "counts": {
          "proteins": 1,
          "patents": 154,
          "drugs": 0,
          "trials": 0,
          "grants": 5229,
          "papers": 15802
        }
      }
    ],
    "columns": [
      {
        "key": "symbol",
        "label": "Gene",
        "under": "name"
      },
      {
        "key": "id",
        "label": "NCBI Gene",
        "under": "hgnc_id"
      },
      {
        "key": "counts.proteins",
        "label": "Proteins"
      },
      {
        "key": "counts.patents",
        "label": "Patents"
      },
      {
        "key": "counts.drugs",
        "label": "Drugs"
      },
      {
        "key": "counts.trials",
        "label": "Trials"
      },
      {
        "key": "counts.grants",
        "label": "NIH grants"
      },
      {
        "key": "counts.papers",
        "label": "Papers"
      }
    ],
    "order": "Most papers first"
  },
  "release": "gene-search-2026-11-11-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ChEMBL, through Open Targets",
      "license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC BY-SA 3.0"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "None stated"
    },
    {
      "source": "EMBL-EBI's patent proteins",
      "license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
      "notice": null,
      "short": "No added restrictions. Attribution expected"
    },
    {
      "source": "GenBank's patent files",
      "license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
      "notice": null,
      "short": "No restrictions from NCBI. Submitters may hold rights"
    },
    {
      "source": "HGNC",
      "license": "CC0: https://www.genenames.org/about/license/",
      "notice": null,
      "short": "CC0"
    },
    {
      "source": "NCBI Gene",
      "license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
      "notice": null,
      "short": "None named. Public domain as US government information"
    },
    {
      "source": "NIH's project files and grant-paper links",
      "license": "Public domain (NIH RePORTER)",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "Open Targets",
      "license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC0 1.0"
    },
    {
      "source": "PubTator 3",
      "license": "Public domain",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "UniProt",
      "license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
      "notice": null,
      "short": "CC BY 4.0"
    }
  ],
  "next": "/api/genes/v1?page=25",
  "request_id": "WUo_r79Ffd5C1YPz"
}